These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19050276)

  • 21. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
    Gorman MJ; Poddar S; Farzan M; Diamond MS
    J Virol; 2016 Sep; 90(18):8212-25. PubMed ID: 27384652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 T Cell Determinants in West Nile Virus Disease and Asymptomatic Infection.
    Koblischke M; Spitzer FS; Florian DM; Aberle SW; Malafa S; Fae I; Cassaniti I; Jungbauer C; Knapp B; Laferl H; Fischer G; Baldanti F; Stiasny K; Heinz FX; Aberle JH
    Front Immunol; 2020; 11():16. PubMed ID: 32038660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.
    Sitati EM; Diamond MS
    J Virol; 2006 Dec; 80(24):12060-9. PubMed ID: 17035323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain.
    Welte T; Xie G; Wicker JA; Whiteman MC; Li L; Rachamallu A; Barrett A; Wang T
    Vaccine; 2011 Jun; 29(29-30):4853-61. PubMed ID: 21549792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
    Martina BE; Koraka P; van den Doel P; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2008 Jan; 26(2):153-7. PubMed ID: 18069096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. West Nile Virus Vaccine Design by T Cell Epitope Selection:
    Waller FM; Reche PA; Flower DR
    J Immunol Res; 2020; 2020():7235742. PubMed ID: 32258174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance.
    Acharya D; Wang P; Paul AM; Dai J; Gate D; Lowery JE; Stokic DS; Leis AA; Flavell RA; Town T; Fikrig E; Bai F
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
    Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-1R1 signaling regulates CXCL12-mediated T cell localization and fate within the central nervous system during West Nile Virus encephalitis.
    Durrant DM; Daniels BP; Klein RS
    J Immunol; 2014 Oct; 193(8):4095-106. PubMed ID: 25200953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.
    Shrestha B; Ng T; Chu HJ; Noll M; Diamond MS
    Vaccine; 2008 Apr; 26(16):2020-33. PubMed ID: 18339459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
    Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G
    Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
    Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.
    Shrestha B; Zhang B; Purtha WE; Klein RS; Diamond MS
    J Virol; 2008 Sep; 82(18):8956-64. PubMed ID: 18632856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High clonality of virus-specific T lymphocytes defined by TCR usage in the brains of mice infected with West Nile virus.
    Kitaura K; Fujii Y; Hayasaka D; Matsutani T; Shirai K; Nagata N; Lim CK; Suzuki S; Takasaki T; Suzuki R; Kurane I
    J Immunol; 2011 Oct; 187(8):3919-30. PubMed ID: 21908734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination.
    Smith HL; Monath TP; Pazoles P; Rothman AL; Casey DM; Terajima M; Ennis FA; Guirakhoo F; Green S
    J Infect Dis; 2011 Feb; 203(4):513-22. PubMed ID: 21216868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine.
    Nelson MH; Winkelmann E; Ma Y; Xia J; Mason PW; Bourne N; Milligan GN
    Vaccine; 2010 Dec; 29(2):174-82. PubMed ID: 21055493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.
    Winkelmann ER; Widman DG; Xia J; Ishikawa T; Miller-Kittrell M; Nelson MH; Bourne N; Scholle F; Mason PW; Milligan GN
    Vaccine; 2012 Feb; 30(8):1465-75. PubMed ID: 22226862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
    Throsby M; Ter Meulen J; Geuijen C; Goudsmit J; de Kruif J
    Expert Rev Vaccines; 2007 Apr; 6(2):183-91. PubMed ID: 17408368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.